ABC | Volume 113, Nº3, Setembro 2019

Minieditorial Sobral Filho e Monteiro Júnior Ativação plaquetária na aterotrombose coronariana Arq Bras Cardiol. 2019; 113(3):364-366 Este é um artigo de acesso aberto distribuído sob os termos da licença de atribuição pelo Creative Commons 12. Calvieri C, Tanzilli G, Bartimoccia S, Cangemi R, Arrivi A, Dominici M, et al. Interplay between Oxidative Stress and Platelet Activation in Coronary Thrombus of STEMI Patients. Antioxidants (Basel). 2018;7(7) pii:E83. 13. Carnevale R, Bartimoccia S, Nocella C, Di Santos S, Loffredo L, Illuminati G, et al. LDL oxidation by platelets propagates platelet activation via an oxidative stress mediatedmechanism. Atherosclerosis. 2014;237(1):108-116. 14. Patrono C, Morais J, Baigent C, Collet JP , Fitzgerald D, Halvorsen S, et al. Antiplatelet Agents for the Treatment and Prevention of Coronary Atherothrombosis. J Am Coll Cardiol. 2017;70(14):1760-76. 15. Monteiro Júnior JGM, de Oliveira CTD, Filho DCS. Hematological parameters as prognostic biomarkers in patients with cardiovascular diseases. Curr Cardiol Rev. 2019;15(4):274-82. 16. Uysal HB, Dagli B, Akgullu C, Ayal M, Xancir C, AyhanM, et al. Blood count parameters can predict the severity of coronary artery disease. Korean J Intern Med 2016; 31(6) 1093-100. 17. Violi F, Pignatelli P. Platelet Oxidative Stress and Thrombosis. Thromb Res. 2012;129(3):378-81. 18. Hovens MM, Snoep JD, Eikenboom JC, van der Bom JG, Mertens BJ, Huisman MV. Prevalence of persistent platelet reactivity despite use of aspirin: a systematic review. AmHeart J. 2007;153(2):175-81. 19. Buyukasik Y, Karakus S, Goker H, Haznedaroglu IC, Ozatli D, Sayinalp N, et al. Rational use of the PFA-100 device for screening of platelet function disorders and von Willebrand disease. Blood Coagul Fibrinolysis. 2002;13(4):349-53. 20. Lordkipanidzé M, Pharand C, Schampaert E, Turgeon J, Palisaitis DA, Diodati JG. A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease. Eur Heart J. 2007;28(14):1702-8. 21. Ivandic BT, Giannitsis E, Schlick P, Staritz P, Katus HA, Hohlfeld T. Determination of aspirin responsiveness by use of whole blood platelet aggregometry. Clin Chem. 2007;53(4):614-9. 366